Project m-Maitri: Interactive Voice Response (IVR) for Parent-to-Child Transmission

Source
SAATHI

In 2016, Solidarity and Action Against the HIV Infection in India began a partnership with Janssen Global Public Health, an initiative of the Janssen Pharmaceutical Companies of Johnson & Johnson. The initiative, named m-Maitri, aimed to complement on-the-ground efforts at ensuring retention in the prevention of parent-to-child transmission cascade with interactive voice response (IVR) to consenting pregnant women and mother-baby pairs until the babies reach 18 months of age.

Messages commence in the antenatal period and until 18 months post-delivery. The service delivers customized messaging relevant to the woman’s stage of pregnancy and her infant’s development, and covers issues such as nutrition for mother and child, immunization, infections such as HIV, TB and malaria,  anti-retroviral prophylaxis and treatment, safe delivery, early infant diagnosis and retention in care, and many other health behaviors. SAATHII's technology partner in this initiative is Mahiti, and IVRS partner is IMIMobile.

A case study reveals more details about the program.